Home > Healthcare > Pharmaceuticals > Finished Drug Form > Neutropenia Treatment Market

Neutropenia Treatment Market Share

Report ID: GMI8441
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Neutropenia Treatment Market Share

The neutropenia treatment industry is characterized by intense competition among key players striving to innovate and develop effective treatments to cater to the patient needs with neutropenia. Major pharmaceutical and biotechnology companies are focusing on key strategies employed including product innovation, strategic partnerships, mergers and acquisitions, and geographical expansions to gain a competitive edge.

Neutropenia Treatment Market Companies

Prominent players operating in the neutropenia treatment industry are as mentioned below:

Amgen Inc.
BeyondSpring Inc.
Biocon Biologics Inc.
Cellerant Therapeutics
Coherus BioSciences, Inc.
CuraTeQ Biologics Pvt. Ltd.
Evive Biotech
Kyowa Kirin Co., Ltd.
Pfizer Inc.
Sandoz Inc.
Spectrum Pharmaceuticals
Teva Pharmaceutical Industries Ltd.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of neutropenia treatment was reached USD 14.5 billion in 2023 and is expected to register over 4.1% CAGR from 2024 to 2032, owing to the increasing prevalence of neutropenia, marked by abnormally low neutrophil levels which intensified the demand for neutropenia treatment worldwide.

Neutropenia treatment industry from the colony-stimulating factors segment is set to exceed USD 13 billion by 2032, due to its ability to stimulate the production of white blood cells, specifically neutrophils, which are crucial for combating infections.

North America neutropenia treatment industry is expected to record USD 7.4 billion by 2032 due to increasing cancer prevalence, demand for disease-specific treatment, robust healthcare spending, well-established infrastructure, and the presence of key market players in the region.

Biocon Biologics Inc., Cellerant Therapeutics, Coherus BioSciences, Inc., CuraTeQ Biologics Pvt. Ltd., Evive Biotech, Kyowa Kirin Co., Ltd., Pfizer Inc., Sandoz Inc., Spectrum Pharmaceuticals, and Teva Pharmaceutical Industries Ltd. are some of the major neutropenia treatment companies worldwide.